BG107806A - Състав, включващ камптотецинови и стилбенови производни, за лечение на рак - Google Patents

Състав, включващ камптотецинови и стилбенови производни, за лечение на рак Download PDF

Info

Publication number
BG107806A
BG107806A BG107806A BG10780603A BG107806A BG 107806 A BG107806 A BG 107806A BG 107806 A BG107806 A BG 107806A BG 10780603 A BG10780603 A BG 10780603A BG 107806 A BG107806 A BG 107806A
Authority
BG
Bulgaria
Prior art keywords
combretastatin
cpt
combination
treatment
camptothecin
Prior art date
Application number
BG107806A
Other languages
Bulgarian (bg)
English (en)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG107806A publication Critical patent/BG107806A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG107806A 2000-10-27 2003-05-12 Състав, включващ камптотецинови и стилбенови производни, за лечение на рак BG107806A (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24343100P 2000-10-27 2000-10-27
US24558200P 2000-11-06 2000-11-06
US25013800P 2000-12-01 2000-12-01
PCT/EP2001/012985 WO2002034244A2 (en) 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer

Publications (1)

Publication Number Publication Date
BG107806A true BG107806A (bg) 2004-06-30

Family

ID=27399663

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107806A BG107806A (bg) 2000-10-27 2003-05-12 Състав, включващ камптотецинови и стилбенови производни, за лечение на рак

Country Status (22)

Country Link
US (1) US6562834B2 (no)
EP (1) EP1333820A2 (no)
JP (1) JP2004517821A (no)
KR (1) KR100742524B1 (no)
CN (1) CN1200712C (no)
AU (2) AU1602902A (no)
BG (1) BG107806A (no)
BR (1) BR0114856A (no)
CA (1) CA2426898A1 (no)
EA (1) EA005400B1 (no)
EE (1) EE200300184A (no)
HK (1) HK1058623A1 (no)
HR (1) HRP20030382A2 (no)
HU (1) HUP0302629A3 (no)
IL (1) IL155509A0 (no)
MX (1) MXPA03002882A (no)
NO (1) NO324844B1 (no)
NZ (1) NZ524855A (no)
PL (1) PL365685A1 (no)
SK (1) SK5122003A3 (no)
WO (1) WO2002034244A2 (no)
YU (1) YU29803A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183266A1 (en) * 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
US7850990B2 (en) * 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
CA2383259A1 (en) * 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
TW200819409A (en) 2006-10-19 2008-05-01 Univ Taipei Medical Z-stilbenes derivatives and the pharmaceutical composition thereof
CA2826034A1 (en) 2011-01-28 2012-08-02 University Of Kentucky Research Foundation Stilbene analogs and methods of treating cancer
AU2012275841A1 (en) 2011-06-27 2014-01-16 The Jackson Laboratory Methods and compositions for treatment of cancer and autoimmune disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS57116015A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Antitumor agent
JPS57116074A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS58154582A (ja) 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
JPS595188A (ja) 1982-06-30 1984-01-12 Yakult Honsha Co Ltd １０−ヒドロキシカンプトテシンの製造法
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
CA1332413C (en) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US5004758A (en) 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JP2524804B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体及びその製造法
JP2524803B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
EP0540099B1 (en) 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
TW334418B (en) 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
GB9510716D0 (en) 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5663177A (en) 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5670500A (en) 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
PT835258E (pt) 1995-06-21 2003-02-28 Sod Conseils Rech Applic Novos analogos de camptotecina, processos para a sua preparacao, sua utilizacao como farmacos e composicoes farmaceuticas que os contem
JP3054669B2 (ja) 1995-10-16 2000-06-19 余川商事株式会社 積雪落下防止装置
JPH11296051A (ja) 1998-04-08 1999-10-29 Canon Inc プロセスカートリッジ
DE69942128D1 (de) * 1998-12-11 2010-04-22 Coulter Pharm Inc Prodrugs und verfahren zu deren herstellung
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
CA2432792C (en) 2000-12-22 2012-04-03 Bristol-Myers Squibb Company Methods for modulating tumor growth and metastasis

Also Published As

Publication number Publication date
JP2004517821A (ja) 2004-06-17
KR20030082544A (ko) 2003-10-22
NO20031656L (no) 2003-04-10
IL155509A0 (en) 2003-11-23
HUP0302629A2 (hu) 2003-11-28
AU2002216029B2 (en) 2006-01-05
US20020115677A1 (en) 2002-08-22
HK1058623A1 (en) 2004-05-28
US6562834B2 (en) 2003-05-13
HUP0302629A3 (en) 2005-05-30
PL365685A1 (en) 2005-01-10
CN1471396A (zh) 2004-01-28
NO20031656D0 (no) 2003-04-10
EA200300516A1 (ru) 2003-08-28
NO324844B1 (no) 2007-12-17
HRP20030382A2 (en) 2005-04-30
WO2002034244A2 (en) 2002-05-02
MXPA03002882A (es) 2004-12-03
SK5122003A3 (en) 2003-12-02
BR0114856A (pt) 2004-06-15
KR100742524B1 (ko) 2007-08-02
EE200300184A (et) 2003-08-15
NZ524855A (en) 2004-10-29
AU1602902A (en) 2002-05-06
EA005400B1 (ru) 2005-02-24
WO2002034244A3 (en) 2003-05-30
CA2426898A1 (en) 2002-05-02
CN1200712C (zh) 2005-05-11
YU29803A (sh) 2006-05-25
EP1333820A2 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
US6214860B1 (en) Synergistic antitumor composition containing a naphthalensulphonic acid derivative
AU2016336133B2 (en) Combination therapies for treating cancer
US20030118667A1 (en) Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer
AU2005294432A1 (en) Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection
RU2396952C2 (ru) Комбинация, включающая комбретастатин и противораковые средства
CZ302451B6 (cs) Protirakovinová farmaceutická kombinace
JP2005008534A (ja) 抗癌剤及び癌の治療方法
WO2017158570A1 (en) Method of treating triple negative breast cancer
US20120208883A1 (en) Treatment of oncological diseases
EP3429582A1 (en) Combination therapy for proliferative diseases
US6562834B2 (en) Combination comprising camptothecin and a stilbene derivative for the treatment of cancer
JP2706371B2 (ja) 癌治療用補助剤及びそれを用いたキット
AU2002216029A1 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
US6548488B2 (en) Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
US20030195161A1 (en) Composition comprising camptothecin or a camptothecin derivative and a topoisomerase II inhibitor for the treatment of cancer
ZA200302552B (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer.
KR20010102402A (ko) 상승작용성 항종양 조성물
EP1716852A1 (en) A composition comprising campothecin or a campothecin derivative and an alkylating agent for the treatment of cancer
CA2516097A1 (en) A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent